1. Home
  2. IGC vs MGLD Comparison

IGC vs MGLD Comparison

Compare IGC & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MGLD
  • Stock Information
  • Founded
  • IGC 2005
  • MGLD 1996
  • Country
  • IGC United States
  • MGLD United States
  • Employees
  • IGC N/A
  • MGLD N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • IGC Health Care
  • MGLD Finance
  • Exchange
  • IGC Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • IGC 39.8M
  • MGLD 44.8M
  • IPO Year
  • IGC N/A
  • MGLD N/A
  • Fundamental
  • Price
  • IGC $0.42
  • MGLD $1.05
  • Analyst Decision
  • IGC Strong Buy
  • MGLD
  • Analyst Count
  • IGC 2
  • MGLD 0
  • Target Price
  • IGC $4.00
  • MGLD N/A
  • AVG Volume (30 Days)
  • IGC 1.4M
  • MGLD 18.0K
  • Earning Date
  • IGC 08-14-2025
  • MGLD 11-07-2025
  • Dividend Yield
  • IGC N/A
  • MGLD N/A
  • EPS Growth
  • IGC N/A
  • MGLD N/A
  • EPS
  • IGC N/A
  • MGLD N/A
  • Revenue
  • IGC $1,327,000.00
  • MGLD $31,205,000.00
  • Revenue This Year
  • IGC $15.26
  • MGLD N/A
  • Revenue Next Year
  • IGC $3.41
  • MGLD N/A
  • P/E Ratio
  • IGC N/A
  • MGLD N/A
  • Revenue Growth
  • IGC 24.95
  • MGLD N/A
  • 52 Week Low
  • IGC $0.25
  • MGLD $0.64
  • 52 Week High
  • IGC $0.50
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • IGC 55.05
  • MGLD 60.07
  • Support Level
  • IGC $0.39
  • MGLD $0.98
  • Resistance Level
  • IGC $0.47
  • MGLD $1.15
  • Average True Range (ATR)
  • IGC 0.04
  • MGLD 0.10
  • MACD
  • IGC 0.00
  • MGLD 0.02
  • Stochastic Oscillator
  • IGC 43.67
  • MGLD 78.49

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: